Quartz·1 min read·easy

Eli Lilly's weight-loss pill is approved in the U.K.

Cris Tolomia
AI Summary

The U.K. regulator has approved Eli Lilly's drug orforglipron for the treatment of weight management and type 2 diabetes. This makes the U.K. the first European country to authorize the medication.

The U.K. regulator authorized orforglipron for weight management and type 2 diabetes, making Britain the first country in Europe to clear the drug

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthbusiness

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in